Video

What Is Exciting in CLL Treatment Options?

Mary Golf, PharmD, discusses the latest in research options for CLL management.

In this clip, Mary Golf, PharmD, of Northwestern Memorial Hospital, discusses the latest in research options for chronic lymphocytic leukemia, or CLL, management. She notes that with targeted markers, "the side effects are more focused and managable."

Related Videos
Image credit: JJAVA | stock.adobe.com
Genetic engineering and gene manipulation concept. Hand is replacing part of a DNA molecule - Image credit: vchalup | stock.adobe.com
Pharmacist and patient in a community pharmacy -- Image credit: Gorodenkoff | stock.adobe.com
X-ray image of human brain with neurons -- Image credit: Who is Danny | stock.adobe.com
Related Content
Mother holding baby's foot with measles spots | Image Credit: © rostock-studio - stock.adobe.com
April 18th 2025

Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Ozempic Insulin injection pen for diabetics. Concept of losing weight with the drug Image credit: Kassandra | stock.adobe.com
April 18th 2025

Study: Vision Impairment Signals Linked to Semaglutide Use

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Allergic asthma airways -- Image credit: Thipphaphone | stock.adobe.com
April 18th 2025

Alternative Methods in Identifying Allergic, Nonallergic Type 2 Asthma Endotypes Are Necessary

Gillian McGovern, Associate Editor
LDL (Bad) lipoprotein (cholesterol) in the blood flow – Closeup view 3d illustration
April 18th 2025

Lepodisiran Reduces Lipoprotein(a) By Nearly 94% in Adults With Elevated Levels of Lp(a)

Luke Halpern, Assistant Editor